4DMT Announces Positive Interim Data from 4D-150 SPECTRA Clinical Trial in DME and Alignment with FDA on Registrational Path
Across all DME patients dosed to date, 4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose ...
CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025
SAN CARLOS, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to advance next-generation, potentially curative cell ...
QNX, Vector and TTTech Auto Join Forces to Develop Foundational Vehicle Software Platform to Turbocharge Auto Innovation
Industry heavyweights in safe and secure operating system, middleware and tooling combine their collective know-how to eliminate software integration complexities so OEMs can focus on brand differenti ...